The role of neutrophil extracellular trap in severity of acute pancreatitis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044668

Enrollment

Unknown

Registered

2021-03-25

Start date

2021-04-01

Completion date

Unknown

Last updated

2021-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis

Interventions

Mild acute pancreatitis group:None

Moderate severe acute pancreatitis group:None

Severe acute pancreatitis group:None

Healthy control group:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 and 80 years; 2. Confirmed diagnosis of acute pancreatitis; 3. Within 72h after the onset of abdominal pain; 4. Informed consent obtained from all patients or their legal representatives prior to randomization.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactation women; 2. Combined with any end-stage tumors; 3. Patient in a moribund state(estimated dead within 12h); 4. Combined with any end-stage comorbidities; 5. Participating in clinical trials which may affect the results of this trial.

Design outcomes

Primary

Measure	Time frame
Proteomic analysis of neutrophil;Apoptosis of neutrophil;Blood biochemical indexes;Disease severity indexes;Macrophage phagocytosis;Macrophage phenotype;Neutrophil extracellular trap;	—

Countries

China

Contacts

Public ContactXiaoxin Zhang

West China Hospital, Sichuan University

zhangxxmed@163.com+86 13438295523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026